ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Arclin plans to expand capacity for methylamines and the derivative dimethylformamide (DMF) at its facility in Belle, West Virginia. The company, the sole US producer of DMF and other methylamides, says demand is growing as US companies reshore manufacturing. Arclin plans to double DMF output and increase methylamine capacity by 35%. It acquired the Belle plant, once part of DuPont and later Chemours, in 2023.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter